BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 9309400)

  • 1. Morphology of Barrett's esophagus and Barrett's-associated dysplasia and adenocarcinoma.
    Antonioli DA; Wang HH
    Gastroenterol Clin North Am; 1997 Sep; 26(3):495-506. PubMed ID: 9309400
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An endoscopic biopsy protocol can differentiate high-grade dysplasia from early adenocarcinoma in Barrett's esophagus.
    Levine DS; Haggitt RC; Blount PL; Rabinovitch PS; Rusch VW; Reid BJ
    Gastroenterology; 1993 Jul; 105(1):40-50. PubMed ID: 8514061
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparative cytopathologic and histologic study of atypia, dysplasia, and adenocarcinoma in Barrett's esophagus.
    Geisinger KR; Teot LA; Richter JE
    Cancer; 1992 Jan; 69(1):8-16. PubMed ID: 1727677
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The relationship between columnar epithelial dysplasia and invasive adenocarcinoma arising in Barrett's esophagus.
    Hamilton SR; Smith RR
    Am J Clin Pathol; 1987 Mar; 87(3):301-12. PubMed ID: 3825997
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endoscopic biopsy can detect high-grade dysplasia or early adenocarcinoma in Barrett's esophagus without grossly recognizable neoplastic lesions.
    Reid BJ; Weinstein WM; Lewin KJ; Haggitt RC; VanDeventer G; DenBesten L; Rubin CE
    Gastroenterology; 1988 Jan; 94(1):81-90. PubMed ID: 3335302
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dysplasia in Barrett's esophagus. A clinicopathologic study of six patients.
    Lee RG
    Am J Surg Pathol; 1985 Dec; 9(12):845-52. PubMed ID: 2416226
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is there an advantage to be gained from adding digital image cytometry of brush cytology to a standard biopsy protocol in patients with Barrett's esophagus?
    Borovicka J; Schönegg R; Hell M; Kradolfer D; Bauerfeind P; Dorta G; Netzer P; Binek J; Meyenberger C; Fischer JE; Spieler P
    Endoscopy; 2009 May; 41(5):409-14. PubMed ID: 19418394
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Barrett's esophagus, high-grade dysplasia, and early adenocarcinoma: a pathological study.
    Cameron AJ; Carpenter HA
    Am J Gastroenterol; 1997 Apr; 92(4):586-91. PubMed ID: 9128304
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of brush cytology in the diagnosis of Barrett's esophagus: an analysis of eight cases.
    Padmavathy F; Siddaraju N; Sistla SC
    Diagn Cytopathol; 2011 Jan; 39(1):60-4. PubMed ID: 21162095
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictors of Progression to High-Grade Dysplasia or Adenocarcinoma in Barrett's Esophagus.
    Whitson MJ; Falk GW
    Gastroenterol Clin North Am; 2015 Jun; 44(2):299-315. PubMed ID: 26021196
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Computer-assisted brush-biopsy analysis for the detection of dysplasia in a high-risk Barrett's esophagus surveillance population.
    Anandasabapathy S; Sontag S; Graham DY; Frist S; Bratton J; Harpaz N; Waye JD
    Dig Dis Sci; 2011 Mar; 56(3):761-6. PubMed ID: 20978843
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methylene blue staining of dysplastic and nondysplastic Barrett's esophagus: an in vivo and ex vivo study.
    Canto MI; Setrakian S; Willis JE; Chak A; Petras RE; Sivak MV
    Endoscopy; 2001 May; 33(5):391-400. PubMed ID: 11396755
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Brush cytology in the diagnosis of neoplasia in Barrett's esophagus.
    Hardwick RH; Morgan RJ; Warren BF; Lott M; Alderson D
    Dis Esophagus; 1997 Oct; 10(4):233-7. PubMed ID: 9455648
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of Barrett's esophagus with high-grade dysplasia.
    McAllaster JD; Buckles D; Al-Kasspooles M
    Expert Rev Anticancer Ther; 2009 Mar; 9(3):303-16. PubMed ID: 19275509
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Minute adenocarcinoma on Barrett's esophagus: the importance of directed biopsy sampling.
    Sastre Lozano VM; Vicente López JJ; Morán Sánchez S
    Rev Esp Enferm Dig; 2019 Feb; 111(2):164. PubMed ID: 30318897
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acidic fibroblast growth factor is expressed sequentially in the progression from Barrett's esophagus to esophageal adenocarcinoma.
    Soslow RA; Petersen CG; Remotti H; Altorki N
    Dis Esophagus; 2001; 14(1):23-7. PubMed ID: 11422301
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prospective multivariate analysis of clinical, endoscopic, and histological factors predictive of the development of Barrett's multifocal high-grade dysplasia or adenocarcinoma.
    Weston AP; Badr AS; Hassanein RS
    Am J Gastroenterol; 1999 Dec; 94(12):3413-9. PubMed ID: 10606296
    [TBL] [Abstract][Full Text] [Related]  

  • 18. How Should We Report Endoscopic Results in Patient's with Barrett's Esophagus?
    Gorrepati VS; Sharma P
    Dig Dis Sci; 2018 Aug; 63(8):2115-2121. PubMed ID: 29675664
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Usefulness of cytopathology and histology in the evaluation of Barrett's esophagus in a community hospital.
    Alexander JA; Jones SM; Smith CJ; Doull JA; Gietzen TH; Rathgaber SW
    Gastrointest Endosc; 1997 Oct; 46(4):318-20. PubMed ID: 9351033
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dysplasia in Barrett's esophagus.
    Schmidt HG; Riddell RH; Walther B; Skinner DB; Riemann JF
    J Cancer Res Clin Oncol; 1985; 110(2):145-52. PubMed ID: 4044629
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.